Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil

Urologia Internationalis

Volumn 80, Issue 3, 2008, Pages 249-252

  Iacono, Fabrizio ^a,c   Prezioso, Domenico ^a   Somma, Pasquale ^b   Chierchia, Stefania ^a   Galasso, Raffaele ^a   Micheli, Pietro ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^c Parco Matarazzo   (Italy)

Author keywords

Cavernous fibrosis; Cavernous microarchitecture; Corpora cavernosa; Erectile dysfunction; Post prostatectomy cavernosal fibrosis; Radical prostatectomy; Sildenafil

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONNECTIVE TISSUE; CORPUS CAVERNOSUM; CORPUS CAVERNOSUM FIBROSIS; ELASTIC FIBER; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PENIS DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STAINING; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PENILE DISEASES; PENIS; PIPERAZINES; PROSTATECTOMY; PURINES; SULFONES;

EID: 43749115557     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127335     Document Type: Article

References (20)

1. Aref I: Surgical management of prostate cancer. Cancer 1995;76:1682-1684.
2. Quinlan DM, Epstein JI, Carter BS, Walsh PC: Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991;145:998-1002.
3. Goldstein AM, Padma-Nathan H: The microarchitecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton. J Urol 1990;144:1144-1146.
4. Goldstein AM, Meehan JP, Morrow JW, Buckley PA, Rogers FA: The fibrous skeleton of the corpora cavernosa and its probable function in the mechanism of erection. Br J Urol 1985;57:574-578.
5. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V: Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005;173:1673-1676.
6. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ: Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24:239-245.
7. Persson C, Diederichs W, Lue T, Yen TSB, Fishman IJ, McLin PH, Tanagho E: Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol 1989;142:1462-1468.
8. Iacono F, Barra S, De Rosa G, Boscaino A, Lotti T: Microstructural disorders of tunica albuginea in patients affected by impotence. Eur Urol 1994;26:233-239.
9. Mehta S: Sildenafil for pulmonary arterial hypertension: exciting, but protection required. Chest 2003;123:989-992.
10. Prasad S, Wilkinson J, Gatzoulis MA: Sildenafil in primary pulmonary hypertension. N Engl J Med 2000;343:1342.
11. Sastry BK, Narasimhan C, Reddy NK, Anand B, Prakash GS, Raju PR, Kumar DN: A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J 2002;54:410-414.
12. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, Ermert M, Weissman N, Rose F, Guenther A, Walmrath D, Seeger W, Grimminger F: Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 2004;169:39-45.
13. Schwartz EJ, Wong P, Graydon RJ: Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771-774.
14. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL: Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004;45:123-133.
15. Moreland RB: Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113-120.
16. Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B, Schermuly RT, Weissmann N, Seeger W, Grimminger F: Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2004;44:1488-1499.
17. Miyao N, Adachi H, Sato Y, Horita H, Takahashi A, Masumori N, Kitamura H, Tsukamoto T: Recovery of sexual function after nerve-sparing radical prostatectomy or cystectomy. J Urol 2001;8:158-164.
18. Nandipati KC, Raina R, Agarwal A, Zippe CD: Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs Aging 2006;23:101-117.
19. Perugia G, Liberti M, Vicini P, Colistro F, Gentile V: Use of local hyperthermia as prophylaxis of fibrosis and modification in penile length following radical retropubic prostatectomy. Int J Hyperthermia 2005;21:359-365.
20. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J: Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006;68:429-435.